Gastaldi Giorgio, Felice Pietro, Pistilli Valeria, Barausse Carlo, Ippolito Daniela Rita, Esposito Marco
Eur J Oral Implantol. 2018;11(1):49-61.
To evaluate whether 5.0 × 5.0 mm dental implants with a novel nanostructured calcium-incorporated titanium surface could be an alternative to implants of at least 10.0 mm long placed in bone augmented with bone substitutes in posterior atrophic jaws.
Forty patients with atrophic posterior (premolar and molar areas) mandibles with 5.0 mm to 7.0 mm bone height above the mandibular canal, and 40 patients with atrophic maxillas with 4.0 mm to 6.0 mm below the maxillary sinus, were randomised according to a parallel group design to receive between one and three 5.0 mm implants or one to three at least 10.0 mm-long implants in augmented bone at two centres. All implants had a diameter of 5.0 mm. Mandibles were vertically augmented with interpositional bovine bone blocks covered with resorbable barriers. Implants were placed after 4 months. Maxillary sinuses were augmented with particulated porcine bone via a lateral window covered with resorbable barriers, and implants were placed simultaneously. All implants were submerged and loaded after 4 months with provisional prostheses. Four months later, definitive screw-retained or provisionally cement metal-ceramic or zirconia prostheses were delivered. Patients were followed to 3 years post-loading and the outcome measures were: prosthesis and implant failures, any complication, and peri-implant marginal bone level changes.
Seven patients dropped out before the 3-year evaluation (two short mandibles, one short maxilla, two augmented mandibles and two augmented maxillae). In mandibles, two grafted patients were not prosthetically rehabilitated because of multiple complications and two implants failed in the same patient (the second was a replacement implant) vs one patient who lost a short implant and crown 2 years after loading. In maxillas one short implant failed with its provisional crown 3 months post-loading. There were no statistically significant differences in prostheses (difference in proportion = 0.001; 95% CI: -0.12 to 0.13; P = 1.000) and implant failures (difference in proportion = 0.00; 95% CI: -0.13 to 0.13; P = 1.000) up to 3 years after loading. Significantly, more complications occurred at mandibular grafted sites: 17 augmented patients were affected by complications vs eight patients treated with short implants in mandibles (difference in proportion = 0.43; 95% CI: 0.13 to 0.64; P = 0.008). In the maxilla, six sinus-lifted patients vs two patients treated with short implants were affected by complications; the difference not being statistically significant (difference in proportion = 0.21; 95% CI: -0.05 to 0.45; P = 0.232). Patients with mandibular short implants lost on average 1.10 mm of peri-implant bone at 3 years and patients with 10.0 mm or longer mandibular implants lost 1.39 mm. Patients with maxillary short implants lost on average 1.04 mm of peri-implant bone at 3 years and patients with 10 mm or longer maxillary implants lost 1.43 mm. Longer implants showed a greater bone loss up to 3 years after loading than short implants both in maxillae (mean difference: -0.39 mm; 95% CI: -0.70 to -0.07 mm; P = 0.017) and in mandibles (mean difference: -0.29 mm; 95% CI: -0.53 to -0.05 mm; P = 0.020).
Three years after loading, 5.0 mm × 5.0 mm implants achieved similar results than longer implants placed in augmented bone. Short implants might be a preferable choice to bone augmentation especially in posterior mandibles since the treatment is faster, cheaper and associated with less morbidity. However, 5- to 10-year post-loading data are necessary before making reliable recommendations.
评估具有新型纳米结构钙结合钛表面的5.0×5.0毫米牙种植体是否可替代至少10.0毫米长的种植体,后者植入后牙萎缩颌骨中用骨替代物增强的骨内。
40例下颌后牙区(前磨牙和磨牙区)萎缩患者,下颌管上方骨高度为5.0毫米至7.0毫米,40例上颌萎缩患者,上颌窦下方骨高度为4.0毫米至6.0毫米,根据平行组设计随机分组,在两个中心接受1至3枚5.0毫米种植体或1至3枚至少10.0毫米长的种植体植入增强骨内。所有种植体直径均为5.0毫米。下颌骨通过覆盖可吸收屏障的间置牛骨块进行垂直增强。4个月后植入种植体。上颌窦通过覆盖可吸收屏障的外侧窗口用颗粒状猪骨进行增强,并同时植入种植体。所有种植体均为潜入式,4个月后用临时假体加载。4个月后,交付最终的螺丝固位或临时粘结的金属陶瓷或氧化锆假体。对患者进行随访至加载后3年,结果指标包括:假体和种植体失败、任何并发症以及种植体周围边缘骨水平变化。
7例患者在3年评估前退出(2例下颌短种植体患者、1例上颌短种植体患者、2例下颌增强患者和2例上颌增强患者)。在下颌骨中,2例移植患者因多种并发症未进行修复,1例患者的2枚种植体失败(第二枚为替换种植体),而1例患者在加载后2年丢失了1枚短种植体及其牙冠。在上颌骨中,1枚短种植体在加载后第3个月与其临时牙冠一起失败。加载后3年内,假体失败(比例差异=0.001;95%CI:-0.12至0.13;P=1.000)和种植体失败(比例差异=0.00;95%CI:-0.13至0.13;P=1.000)无统计学显著差异。值得注意的是,下颌移植部位发生的并发症更多:17例增强患者出现并发症,而下颌短种植体治疗的患者中有8例出现并发症(比例差异=0.43;95%CI:0.13至0.64;P=0.008)。在上颌骨中,6例上颌窦提升患者与2例短种植体治疗患者出现并发症;差异无统计学意义(比例差异=0.21;95%CI:-0.05至0.45;P=0.232)。下颌短种植体患者在3年时种植体周围骨平均丧失1.10毫米,下颌10.0毫米或更长种植体患者骨丧失1.39毫米。上颌短种植体患者在3年时种植体周围骨平均丧失1.04毫米,上颌10毫米或更长种植体患者骨丧失1.43毫米。加载后3年内,无论是在上颌骨(平均差异:-0.39毫米;95%CI:-0.70至-0.07毫米;P=0.017)还是下颌骨(平均差异:-0.29毫米;95%CI:-0.53至-0.0)5毫米;P=0.020),较长种植体的骨丧失均比短种植体更大。
加载后3年,5.0毫米×5.0毫米种植体与植入增强骨内的较长种植体取得了相似的结果。短种植体可能是骨增强的更优选择,尤其是在下颌后牙区,因为治疗更快、更便宜且发病率更低。然而,在做出可靠推荐之前,还需要5至10年的加载后数据。